Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12624-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12624-1-AP, RRID:AB_2175250
- Product name
- RBBP8 antibody
- Antibody type
- Polyclonal
- Description
- RBBP8 antibody (Cat. #12624-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references LncRNA-EME1 enhances BRCA1 recruitment and alters repair of DNA damage in cervical cancer radioresistance.
Extrachromosomal DNA replication and maintenance couple with DNA damage pathway in tumors.
TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to immunochemotherapy.
PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells.
Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair.
RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer.
The CTIP-mediated repair of TNF-α-induced DNA double-strand break was impaired by miR-130b in cervical cancer cell.
Li Q, Zhou Z, Li X, Lan Q
Non-coding RNA research 2026 Feb;16:57-69
Non-coding RNA research 2026 Feb;16:57-69
Extrachromosomal DNA replication and maintenance couple with DNA damage pathway in tumors.
Kang X, Li X, Zhou J, Zhang Y, Qiu L, Tian C, Deng Z, Liang X, Zhang Z, Du S, Hu S, Wang N, Yue Z, Xu Y, Gao Y, Dai J, Wang Z, Yu C, Chen J, Wu Y, Chen L, Yao Y, Yao S, Yang X, Yan L, Wen Q, Depies OM, Chan K, Liang X, Li G, Zi Z, Liu X, Gan H
Cell 2025 Jun 26;188(13):3405-3421.e27
Cell 2025 Jun 26;188(13):3405-3421.e27
TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to immunochemotherapy.
Lin H, Zhou J, Li Y, Luo L, Zeng Y, Liang X, Yu J, Ye C, Yang P, Lin Y, Li Y, Zeng L
Biochemical pharmacology 2025 Jul 30;242(Pt 1):117199
Biochemical pharmacology 2025 Jul 30;242(Pt 1):117199
PTIP UFMylation promotes replication fork degradation in BRCA1-deficient cells.
Tan Q, Xu X
The Journal of biological chemistry 2024 Jun;300(6):107312
The Journal of biological chemistry 2024 Jun;300(6):107312
Modulation of cell cycle increases CRISPR-mediated homology-directed DNA repair.
Li G, Yang X, Luo X, Wu Z, Yang H
Cell & bioscience 2023 Nov 25;13(1):215
Cell & bioscience 2023 Nov 25;13(1):215
RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer.
Yu Y, Chen L, Zhao G, Li H, Guo Q, Zhu S, Li P, Min L, Zhang S
Oncogene 2020 Feb;39(6):1273-1289
Oncogene 2020 Feb;39(6):1273-1289
The CTIP-mediated repair of TNF-α-induced DNA double-strand break was impaired by miR-130b in cervical cancer cell.
Yang L, Yang B, Wang Y, Liu T, He Z, Zhao H, Xie L, Mu H
Cell biochemistry and function 2019 Oct;37(7):534-544
Cell biochemistry and function 2019 Oct;37(7):534-544
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The RBBP8 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human RBBP8. This antibody recognizes human, mouse, rat antigen. The RBBP8 antibody has been validated for the following applications: ELISA, WB analysis.